References
- Cahill AG, Odibo AO, Stamilio DM, et al. Screening and treating for primary cytomegalovirus infection in pregnancy: where do we stand? A decision-analytic and economic analysis. Amer J Obstetrics Gynecol. 2009;201:466.e1–467.
- Coll O, Benoist G, Ville Y, Group WPIW, et al. Guidelines on CMV congenital infection. J Perinat Med. 2009;37:433–445.
- Manicklal S, Emery VC, Lazzarotto T, et al. The "silent" global burden of congenital cytomegalovirus. Clin Microbiol Rev. 2013;26:86–102.
- Demmler-Harrison GJ. Cytomegalovirus infection and disease in newborns, infants, children and adolescents. In: UpToDate, Post TW, ed. UpToDate, Waltham, MA [cited 4 Dec 2014].
- Adler SP. Screening for cytomegalovirus during pregnancy. Infect Dis Obstet Gynecol. 2011;2011:1–9.
- Enders G, Daiminger A, Bader U, et al. Intrauterine transmission and clinical outcome of 248 pregnancies with primary cytomegalovirus infection in relation to gestational age. J Clin Virol: Off Publ Pan Amer Soc Clin Virol. 2011;52:244–246.
- Ornoy A, Diav-Citrin O. Fetal effects of primary and secondary cytomegalovirus infection in pregnancy. Reproduct Toxicol (Elmsford, NY). 2006;21:399–409.
- Dollard SC, Grosse SD, Ross DS. New estimates of the prevalence of neurological and sensory sequelae and mortality associated with congenital cytomegalovirus infection. Rev Med Virol. 2007;17:355–363.
- Staras SA, Dollard SC, Radford KW, et al. Seroprevalence of cytomegalovirus infection in the United States, 1988–1994. Clin Infect Dis. 2006;43:1143–1151.
- Nigro G, Anceschi MM, Cosmi EV. Clinical manifestations and abnormal laboratory findings in pregnant women with primary cytomegalovirus infection. BJOG. 2003;110:572–577.
- Guerra B, Simonazzi G, Puccetti C, et al. Ultrasound prediction of symptomatic congenital cytomegalovirus infection. Amer J Obstetrics Gynecol. 2008;198:380.e1–387.
- Bernstein DI. Congenital cytomegalovirus: a now problem, no, really now. Clin Vaccine Immunol: CVI 2017;24:e00491–16.
- Direção-Geral da Saúde. Saúde Reprodutiva – Doenças Infeciosas e Gravidez.pdf. 2000.
- Vide Tavares M, Domingues AP, Tavares M, et al. Cytomegalovirus: is there a place for screening during pregnancy? Acta Medica Portuguesa. 2011;24 Suppl 4:1003–1108.
- Yinon Y, Farine D, Yudin MH, et al. Cytomegalovirus infection in pregnancy. J Obstetrics Gynaecol Canada: JOGC = J D’Obstetrique Gynecol Can: JOGC. 2010;32:355–362.
- Carlson A, Norwitz ER, Stiller RJ. Cytomegalovirus infection in pregnancy: should all women be screened? Rev Obstetrics Gynecol. 2010;3:172–179.
- Maidji E, Nigro G, Tabata T, et al. Antibody treatment promotes compensation for human cytomegalovirus-induced pathogenesis and a hypoxia-like condition in placentas with congenital infection. Amer J Pathol. 2010;177:1298–1310.
- Nigro G, Adler SP, La Torre R, et al. Passive immunization during pregnancy for congenital cytomegalovirus infection. N Engl J Med. 2005;353:1350–1362.
- Leruez-Ville M, Ghout I, Bussieres L, et al. In utero treatment of congenital cytomegalovirus infection with valacyclovir in a multicenter, open-label, phase II study. Amer J Obstetrics Gynecol. 2016;215:462.e1–e10.
- Leruez-Ville M, Ville Y. Fetal cytomegalovirus infection. Best Practice Res Clin Obstetrics Gynaecol. 2017;38:97–107.
- Pasternak B, Hviid A. Use of acyclovir, valacyclovir, and famciclovir in the first trimester of pregnancy and the risk of birth defects. JAMA. 2010;304:859–866.
- Newcombe RG. Two-sided confidence intervals for the single proportion: comparison of seven methods. Statist Med. 1998;17:857–872.
- Wilson EB. Probable inference, the law of succession, and statistical inference. J Amer Stat Assoc. 1927;22:209–212.